Drug Meets Device: The Power of Combination Products

Join MassBio for our first Forum jointly hosted with the Medical Development Group (MDG), a premier organization for leading Medical Device and Medical Technology professionals.

This event is Free and open to the public.

(Registration recommended due to limited space).

TO REGISTER: https://www.massbio.org/events/drug-meets-device-the-power-of-combination-products-1245

Combination products are the best of both worlds; blending drugs and devices in ways that offer patients benefits that neither could offer alone. These include products that deliver drugs in a unique way, such as artificial pancreas systems, and products that use drugs to enhance the function of a device, such as drug eluting stents. Combination product technology has already measurably improved patient outcomes. New technologies to improve the integration of drugs with devices are the focus of both industry R&D and academic research.

Though the potential is great, these technologies also pose unique scientific and regulatory challenges that may not be obvious at the outset. As with all new technologies, an effective business strategy is essential for commercialization.

Our panel of industry experts will explore key issues including:
•Basic science of device-associated drug delivery
•Regulatory pathways for combination products
•Investment strategy
•Intellectual property

Speakers:
•Richard Anders, JD, Founder, Executive Director, Mass Medical Angels
•Andrew Bellinger, MD, PhD, Chief Scientific Officer, Lyndra Co.
•Jonathan C. Bretz, OT/L, MBA, RAC President & Founder, RSQM Associates, LLC
•John Keating, DVM, DACVP, Director of Pathology, CBSET Inc, Lexington, MA

Moderator:
•Ibraheem (Ib) T. Badejo, PhD, Senior Director, New Ventures (Medical Devices), Johnson & Johnson Innovation Center

Live-stream this Forum (http://www.ustream.tv/channel/massbio)